The European baseline series and recommended additions: 2019
Open accessThe DOI matches its Crossref record.
Abstract
The European baseline series (EBS) of haptens (contact allergens) is used throughout Europe as an essential patch test screen to diagnose allergic contact dermatitis as an underlying contributory factor to, or cause of, eczema/dermatitis or other inflammatory dermatoses. Exposure to environmental haptens is continuously changing, and the EBS needs to be adapted to reflect these varying hazards that become a risk to the population following exposure,1 in order to ensure that the haptens tested remain relevant and new frequent haptens are detected. The EBS was last revised in 2015.2 Updates had been undertaken by the European Environmental Contact Dermatitis Research Group on behalf of the ESCD. Criteria for inclusion of haptens within the baseline series have been published.3 After a meeting at the biennial congress of the ESCD in 2016, it was decided to create an open and responsive process to update the EBS. The results of screening with the baseline series have been published by the European Surveillance System of Contact Allergy, which is a working group of the ESCD, and evidence-based changes have been recommended.4, 5 In 2017, a working party of the ESCD was formed that met twice during the year to propose changes largely based on these publications, which were subsequently put out for review to the membership of the ESCD. Following feedback, an update to the EBS was agreed, and is published here (Table 1). In brief, because of infrequent positive results4 and lack of relevance, it was agreed to delete primin 0.01% pet. and clioquinol 5% pet. It was further agreed to add propolis 10% pet. and 2-hydroxyethyl methacrylate (2-HEMA) 2% pet.5 Specifically, despite some cross-reactions, for example, to Myroxylon pereirae, it was the general opinion that propolis was a useful addition, especially where "natural" products were popular. Continuing reports emphasize the increasing relevance of contact allergy to 2-HEMA.6-8 When testing with acrylates is performed, it is important to load the chamber at the time of application, owing to the volatile nature of the hapten.9 Finally, the use of caine mix III 10% pet. instead of benzocaine 5% pet. was agreed, given the publications10, 11 showing the increased sensitivity of the mix in screening for contact sensitivity to local anaesthetics. It was felt that some of the haptens proposed5 did not meet the criteria for inclusion3 but that, while further information was gathered to confirm or refute their importance, centres should consider the potential value of testing with them in their local populations. These recommended additions to the baseline series are shown in Table 2. Active sensitization as a consequence of patch testing remains a significant concern. Although 2-HEMA 2% pet., according to the experience of the centres testing with it, did not result in active sensitization, this has been reported,19 and methyl methacrylate and other low molecular weight acrylates are weak sensitizers20 in the local lymph node assay. There is also a debate about p-phenylenediamine (PPD) 1% pet.21 In children, in whom no relevant exposure has occurred, it would be reasonable to exclude PPD, epoxy resin, and 2-HEMA. In adult males in whom no obvious exposure has occurred, and because of the low detection rate, there is an option to exclude 2-HEMA. It is the intention of the group to institute an iterative process with a biennial update of the EBS coinciding with the Congress of the ESCD to which all members of the ESCD will have the opportunity to contribute.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Goossens, A., & Aerts, O. (2022) · Contact Dermatitis · doi:10.1111/cod.14089 · Cited by 76
Self-citationLidén, C., & White, I. R. (2024) · Contact Dermatitis · doi:10.1111/cod.14523 · Cited by 36
“57 In 2022, it was decided to include BIT in the European baseline series for 2023, while keeping OIT as a recommended addition.”
BackgroundContact allergy to preservatives
Aerts, O., & Goossens, A. (2021) · Contact Dermatitis · doi:10.1007/978-3-030-36335-2_85 · Cited by 14
Self-citationBotvid, S., Søgaard, R., Schwensen, J. F. B., & Johansen, J. D. (2026) · Contact Dermatitis · doi:10.1111/cod.70102 · Cited by 1
Self-citation
Metadata
- Authors
- Wilkinson, M., Gonçalo, M., Aerts, O., Badulici, S., Bennike, N. H., Bruynzeel, D., Dickel, H., Garcia‐Abujeta, J. L., Giménez‐Arnau, A. M., Hamman, C., Isaksson, M., Johansen, J. D., Mahler, V., Niklasson, B., Orton, D., Pigatto, P., Ponyai, G., Rustemeyer, T., Schuttelaar, M. L. A., Spiewak, R., Thyssen, J. P., & Uter, W.
- Venue
- Contact Dermatitis
- Publisher
- Wiley
- Published
- 2018-11-12
- Volume
- 80
- Issue
- 1
- Pages
- 1-4
- ISSN
- 0105-1873 (ISSN-L)
- 1600-0536
- OpenAlex
- W2900984251
- Cited by
- 183
- References
- 0
- FWCI
- 24.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.